Online ISSN: 1947-6027
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.

Increased BRD4-L and BRD4-S Promotes Chemotherapy Resistance in Ovarian Carcinoma

Genes & Cancer

September 13, 2023
PRESS RELEASE: On September 12, 2023, a new research paper was published in Genes & Cancer, entitled, “Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma.” continue reading »

A Novel Chromosomal Abnormality in AML Patient: Case Report and Literature Review

News

July 7, 2023
PRESS RELEASE: On June 28, 2023, a new research paper was published in Genes & Cancer, entitled, “A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: case report and review of literature.” continue reading »

Genes & Cancer | VCP/p97 as a Therapeutic Target in KRAS-Mutant Pancreatic Cancer

News

March 24, 2023
PRESS RELEASE: On March 10, 2023, a new research paper was published in Genes & Cancer, entitled, “VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer.” continue reading »

Genes & Cancer | Severe Herpesvirus Infection Beats Adult T-cell Leukemia/Lymphoma

News

February 24, 2023
PRESS RELEASE: On January 19, 2023, Genes & Cancer published a new editorial, entitled, “Severe herpesvirus infection beats adult T-cell leukemia/lymphoma.” continue reading »

Genes & Cancer | CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

Genes & Cancer

February 10, 2023
PRESS RELEASE: A new review was published in Genes & Cancer on February 1, 2023, entitled, “CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.” continue reading »